{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T10:21:26Z","timestamp":1756635686466,"version":"3.40.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,18]]},"DOI":"10.7759\/cureus.84361","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T03:22:37Z","timestamp":1747624957000},"source":"Crossref","is-referenced-by-count":1,"title":["A 50-Year Delay in the Diagnosis of Takayasu Arteritis: Clinical Presentation and Therapeutic Insights"],"prefix":"10.7759","author":[{"given":"Takuya","family":"Yasuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noboru","family":"Hagino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.23-195","article-title":"Current diagnosis and management of Takayasu arteritis","volume":"64","author":"As C","year":"2023","unstructured":"As C, Danda D. Current diagnosis and management of Takayasu arteritis. Int Heart J. 2023, 64:519-34. 10.1536\/ihj.23-195","journal-title":"Int Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2017.05.034","article-title":"Epidemiology of Takayasu arteritis","volume":"46","author":"Onen F","year":"2017","unstructured":"Onen F, Akkoc N. Epidemiology of Takayasu arteritis. Presse Med. 2017, 46:e197-203. 10.1016\/j.lpm.2017.05.034","journal-title":"Presse Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.55.7.481","article-title":"Takayasu arteritis: a review","volume":"55","author":"Johnston SL","year":"2002","unstructured":"Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J Clin Pathol. 2002, 55:481-6. 10.1136\/jcp.55.7.481","journal-title":"J Clin Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150097","article-title":"Clinical features and outcomes of Takayasu arteritis with neurological symptoms in China: a retrospective study","volume":"42","author":"Yang L","year":"2015","unstructured":"Yang L, Zhang H, Jiang X, et al.. Clinical features and outcomes of Takayasu arteritis with neurological symptoms in China: a retrospective study. J Rheumatol. 2015, 42:1846-52. 10.3899\/jrheum.150097","journal-title":"J Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.209.1.9769819","article-title":"Takayasu arteritis: evaluation of the thoracic aorta with CT angiography","volume":"209","author":"Yamada I","year":"1998","unstructured":"Yamada I, Nakagawa T, Himeno Y, Numano F, Shibuya H. Takayasu arteritis: evaluation of the thoracic aorta with CT angiography. Radiology. 1998, 209:103-9. 10.1148\/radiology.209.1.9769819","journal-title":"Radiology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214642","article-title":"Disease progression of Takayasu arteritis in two patients treated with tocilizumab","volume":"79","author":"Sanchez-Alvarez C","year":"2020","unstructured":"Sanchez-Alvarez C, Koster M, Duarte-Garc\u00eda A, Warrington KJ. Disease progression of Takayasu arteritis in two patients treated with tocilizumab. Ann Rheum Dis. 2020, 79:e21. 10.1136\/annrheumdis-2018-214642","journal-title":"Ann Rheum Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/art.20922","article-title":"Takayasu's arteritis: A study of 104 Italian patients","volume":"53","author":"Vanoli M","year":"2005","unstructured":"Vanoli M, Daina E, Salvarani C, et al.. Takayasu's arteritis: A study of 104 Italian patients. Arthritis Rheum. 2005, 53:100-7. 10.1002\/art.20922","journal-title":"Arthritis Rheum"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-7-201110040-00005","article-title":"Pentraxin-3 as a marker of disease activity in Takayasu arteritis","volume":"155","author":"Dagna L","year":"2011","unstructured":"Dagna L, Salvo F, Tiraboschi M, et al.. Pentraxin-3 as a marker of disease activity in Takayasu arteritis. Ann Intern Med. 2011, 155:425-33. 10.7326\/0003-4819-155-7-201110040-00005","journal-title":"Ann Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2013.04.025","article-title":"Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients","volume":"88","author":"Schmidt J","year":"2013","unstructured":"Schmidt J, Kermani TA, Bacani AK, Crowson CS, Cooper LT, Matteson EL, Warrington KJ. Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients. Mayo Clin Proc. 2013, 88:822-30. 10.1016\/j.mayocp.2013.04.025","journal-title":"Mayo Clin Proc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370420","article-title":"Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate","volume":"37","author":"Hoffman GS","year":"1994","unstructured":"Hoffman GS, Leavitt RY, Kerr GS, Rottem M, Sneller MC, Fauci AS. Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum. 1994, 37:578-82. 10.1002\/art.1780370420","journal-title":"Arthritis Rheum"},{"key":"ref11","article-title":"Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis","volume":"30","author":"Valsakumar AK","year":"2003","unstructured":"Valsakumar AK, Valappil UC, Jorapur V, Garg N, Nityanand S, Sinha N. Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis. J Rheumatol. 2003, 30:1793-8.","journal-title":"J Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-017-3847-6","article-title":"Cyclophosphamide could be a better choice than methotrexate as induction treatment for patients with more severe Takayasu's arteritis","volume":"37","author":"Sun Y","year":"2017","unstructured":"Sun Y, Ma L, Ma L, et al.. Cyclophosphamide could be a better choice than methotrexate as induction treatment for patients with more severe Takayasu's arteritis. Rheumatol Int. 2017, 37:2019-26. 10.1007\/s00296-017-3847-6","journal-title":"Rheumatol Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-007-0596-z","article-title":"Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis","volume":"26","author":"Shinjo SK","year":"2007","unstructured":"Shinjo SK, Pereira RM, Tizziani VA, Radu AS, Levy-Neto M. Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis. Clin Rheumatol. 2007, 26:1871-5. 10.1007\/s10067-007-0596-z","journal-title":"Clin Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2011.633553","article-title":"Short-term effect of leflunomide in patients with Takayasu arteritis: an observational study","volume":"41","author":"de Souza AW","year":"2012","unstructured":"de Souza AW, da Silva MD, Machado LS, Oliveira AC, Pinheiro FA, Sato EI. Short-term effect of leflunomide in patients with Takayasu arteritis: an observational study. Scand J Rheumatol. 2012, 41:227-30. 10.3109\/03009742.2011.633553","journal-title":"Scand J Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab635","article-title":"Efficacy and safety of TNF-\u03b1 antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patients","volume":"61","author":"Mekinian A","year":"2022","unstructured":"Mekinian A, Biard L, Dagna L, et al.. Efficacy and safety of TNF-\u03b1 antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patients. Rheumatology (Oxford). 2022, 61:1376-84. 10.1093\/rheumatology\/keab635","journal-title":"Rheumatology (Oxford)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex493","article-title":"Comment on: Rituximab therapy for Takayasu arteritis: a seven patients experience and a review of the literature","volume":"57","author":"Nakagomi D","year":"2018","unstructured":"Nakagomi D, Kronbichler A, Witte T, Mohammad AJ, Jayne DR. Comment on: Rituximab therapy for Takayasu arteritis: a seven patients experience and a review of the literature. Rheumatology (Oxford). 2018, 57:1309-10. 10.1093\/rheumatology\/kex493","journal-title":"Rheumatology (Oxford)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21636","article-title":"Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup","volume":"64","author":"Schmidt J","year":"2012","unstructured":"Schmidt J, Kermani TA, Bacani AK, Crowson CS, Matteson EL, Warrington KJ. Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup. Arthritis Care Res (Hoboken). 2012, 64:1079-83. 10.1002\/acr.21636","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2005.09.010","article-title":"High TNF-alpha and low IL-2 producing T cells characterize active disease in Takayasu's arteritis","volume":"118","author":"Tripathy NK","year":"2006","unstructured":"Tripathy NK, Gupta PC, Nityanand S. High TNF-alpha and low IL-2 producing T cells characterize active disease in Takayasu's arteritis. Clin Immunol. 2006, 118:154-8. 10.1016\/j.clim.2005.09.010","journal-title":"Clin Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904492","article-title":"Infliximab, azathioprine, or combination therapy for Crohn's disease","volume":"362","author":"Colombel JF","year":"2010","unstructured":"Colombel JF, Sandborn WJ, Reinisch W, et al.. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med. 2010, 362:1383-95. 10.1056\/NEJMoa0904492","journal-title":"N Engl J Med"},{"key":"ref20","article-title":"CftMoHG: Guidelines for the Management of Hepatitis B, 4th ed [book in Japanese]","author":"The Japan Society of Hepatology","year":"2022","unstructured":"The Japan Society of Hepatology. Guidelines for the Management of Hepatitis B, 4th ed [book in Japanese]. Tokyo,  The Japan Society of Hepatology; 2022. https:\/\/www.jsh.or.jp\/lib\/files\/medical\/guidelines\/jsh_guidlines\/B_v4.pdf ."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/352681-a-50-year-delay-in-the-diagnosis-of-takayasu-arteritis-clinical-presentation-and-therapeutic-insights","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T03:22:38Z","timestamp":1747624958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/352681-a-50-year-delay-in-the-diagnosis-of-takayasu-arteritis-clinical-presentation-and-therapeutic-insights"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,18]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.84361","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,18]]}}}